Tag Archives: left atrial appendage closure

El cierre de orejuela es seguro con los nuevos dispositivos

Evolution of Leak in Left Atrial Appendage Closure

Evolution of Leak in Left Atrial Appendage Closure

Atrial fibrillation is common in elderly people and is associated with a higher risk of ischemic stroke. Left atrial appendage occlusion (LAAO) is a valid strategy, especially in patients at high risk of bleeding. The presence of peridevice leak (PDL) has been linked to stroke, although some analyses, such as the PROTEC-AF Study, suggest that

Cierre de orejuela izquierda

Left Atrial Appendage Closure and Concomitant Transcatheter Intervention: Can We?

Several scientific societies support performing left atrial appendage occlusion (LAAO) as a stand-alone procedure, even though it is often associated to other cardiomyopathies requiring transcatheter intervention.  Though still controversial, combining LAAO and any other cardiac intervention might reduce hospitalizations, as well as the need for additional punctures, anesthesia, red tape, a longer stay and higher

TCT 2023 | ALIGN AR trial

TCT 2023 | SWISS-APERO: One-Year Events After Left Atrial Appendage Closure with Amulet or Watchman FLX Device

It has been observed that the persistence of an opening in the left atrial appendage after percutaneous closure (LAAC) is associated with a higher risk of embolic events. Among the most commonly used devices for left atrial appendage closure are the Watchman FLX and Amulet devices. This study, known as SwissApero, represents the first randomized

El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure: As Effective in Men and Women?

Atrial fibrillation is the most prevalent arrhythmia and to prevent its potential complications, we should administer anticoagulants (OACs), either warfarin or the new direct oral anticoagulants (DOACs).  Even though these drugs have been shown effective, they still involve the risk of bleeding, especially gastrointestinal bleeding, which in turn leads to numerous hospitalizations. Left atrial appendage occlusion

El cierre de orejuela es seguro con los nuevos dispositivos

Do Men and Women Present the Same Evolution after Left Atrial Appendage Closure?

Atrial fibrillation is a very frequent type of arrythmia that affects both men and women alike. This entity is associated to higher mortality seeing as it favors stroke and hospitalization for cardiac failure.  At present, one of its valid treatment strategies is left atrial appendage closure, to reduce or prevent stroke and anticoagulation driven bleeding. 

El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure Is a Valid Option

Atrial fibrillation (AF) is the most frequent arrhythmia in patients >55 years old and is related to ischemic stroke due to thrombi formation in the left atrium, particularly in the atrial appendage. To avoid this complication, anticoagulation is indicated, but patients >75 years are at high risk of bleeding, making percutaneous closure of the atrial

El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure Is Safe with the New Devices

Left atrial appendage closure (LAAC) in non-valvular atrial fibrillation with high risk of bleeding has shown promising results with first generation devices (with the Watchman) in the different studies. At present, we have a more modern device, the Watchman FLX, but we do not have much information about it.  To gather more data, researchers looked

Leak periprotésico en cierre de orejuela, algo más que un valor para tener en cuenta

Peridevice Leak in Left Atrial Appendage Closure: more than one value to take into account

According to several registries, incomplete left atrial appendage (LAA) closure has been observed in up to 30% of cases after device implantation. The main cause of this complication is a mismatch between closure device and LAA ostium. The latter is elliptical in shape and varies in length, while the Watchman LAA closure device is round


Antithrombotic Therapy Post Percutaneous Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAO) with Watchman has FDA approval since March 2015, having shown, in the PROTECT-AF and PREVAIL studies, reduced risk of atrial fibrillation driven stroke, by excluding the left atrial appendage form systemic circulation.  Both studies used post procedure standardized protocols involving followup at 45 days and 6 months, imaging, and

10 Encuentro Educativo ProEducar - Intervención Estructural II

9° ProEducar Educational Meeting- Structural Intervention II

Watch again the “9th ProEducar Educational Meeting – Learning with Experts” on Structural Intervention on our Youtube account. The event was held on 11/12/2020 by the ProEducar area and had the participation of almost 300 people. What things will I learn if I watch this video? 03:18 | Anatomical Bases for a Correct Transseptal Puncture.